Healthcare / Plant-based Vaccines Market - Global Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions And By Key Players: EEA Consulting Engineers, Protalix, Kentucky BioProcessing, MEDICAGO, INC.
Plant-based Vaccines Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: EEA Consulting Engineers, Protalix, Kentucky BioProcessing, MEDICAGO, INC.
The global Plant-based Vaccines market size is expected to grow USD 2,805.05 million by 2027, at a CAGR of 13.1% over the forecast period.
Plant-based Vaccines Market Overview
The creation of plant-based vaccinations has been aided by the rapid advancement of plant genetic engineering during the past ten years. Plant-based vaccines have not yet been made available for purchase, yet. In recent years, efforts have been made to create plant-based vaccines using a variety of plants, including rice, maize, potato, carrot, tobacco, lettuce, alfalfa, tomato, peanut, and soybean. Because some plants and their products cannot be consumed directly, the choice of plant for the development of plant-based vaccine dictates the route of administration of the vaccine. Thus, heat or pressure treatments must be considered while developing plant-based vaccines. Since the vaccines produced in seeds are among the most desirable plant types for the development of plant-based vaccinations, cereal crops are one of the most popular types of plants.
Vaccines made from plants provide a number of benefits, such as low production costs, patient acceptance, and antigen stability for long-term storage. One of the most effective ways to lessen the burden of infectious diseases worldwide may be through plant-based vaccinations. Furthermore, unlike standard vaccines, plant-based vaccines contaminated with plant viruses would have a small risk of harming people. The drawbacks of plant-based vaccinations, such as allergic reactions and the danger of them escaping the lab and causing unintended consequences, outweigh their advantages and could impede the market's acceptance and expansion for these vaccines.
Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline plc (GSK) today announce positive efficacy and safety results from the global Phase 3 placebo-controlled efficacy study of Medicago’s plant-based COVID-19 vaccine candidate in combination with GSK’s pandemic adjuvant, conducted in over 24,000 subjects (adults 18 years and above) across six countries.
What are the major Applications, Types and Regions for Plant-based Vaccines Market?
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
Bacterial Vaccine
Viral Vaccine
By Application, it is segmented into
Anti-Infective
Anti-Cancer
Anti-Autoimmune Disease
Plant-based Vaccines Market Regional Analysis
The North American plant-based vaccines market is anticipated to account for the largest share of the overall plant-based vaccines industry. This is because there are numerous producers of plant-based vaccines in the area, many of which have cutting-edge manufacturing facilities in states like Texas. Emerging regions such as Africa and Asia Pacific are expected to have a bigger income opportunity as a result of government, non-profit organizations, and the WHO's efforts to produce plant-based vaccinations to meet the regions' unmet needs.
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Middle East & Africa
Latin America
The Plant-based Vaccines Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Plant-based Vaccines Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
What is our Plant-based Vaccines Market report scope?
Report Attributes
Report Details
Forecast Period 2022 to 2027 CAGR
CAGR of 13.1% over the forecast period (2022-2027)
By Type
Bacterial Vaccine
Viral Vaccine
By Application
Anti-Infective
Anti-Cancer
Anti-Autoimmune Disease
By Companies
EEA Consulting Engineers, Protalix, Kentucky BioProcessing, MEDICAGO, INC., British American Tobacco p.l.c., ICON GENETICS GMBH, CREATIVE BIOLABS, INC., iBio, Inc., LENIOBIO, Lumen Bioscience, Inc., LEAF EXPRESSION SYSTEMS LTD., ZYUS LIFE SCIENCES INC., FRAUNHOFER CMB
Regions Covered
North America
Europe
Asia-Pacific
Rest of the World
Countries Covered
US
Canada
Germany
France
UK
Italy
Spain
Rest of Europe
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
Latin America
Base Year
2022
Historical Year
2017 to 2021
Forecast Year
2022 to 2027
Number of Pages
92
Customization Available
Yes, the report can be customized as per your needs
Key Takeaways from this Plant-based Vaccines Market Report
Evaluate Plant-based Vaccines market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.
Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.
Analyze the sales and distribution channels across geographies to enhance top-line revenues.
Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the Plant-based Vaccines market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.
Frequently Asked Questions
What is the growth rate of Plant-based Vaccines Market?
The Plant-based Vaccines Market is growing at a CAGR of 13.1% over the next 5 years.
Who are the key players in Plant-based Vaccines Market?
EEA Consulting Engineers, Protalix, Kentucky BioProcessing, MEDICAGO, INC., British American Tobacco p.l.c., ICON GENETICS GMBH, CREATIVE BIOLABS, INC., iBio, Inc., LENIOBIO, Lumen Bioscience, Inc., LEAF EXPRESSION SYSTEMS LTD., ZYUS LIFE SCIENCES INC., FRAUNHOFER CMB
What are the significant types of Plant-based Vaccines Market?
Bacterial Vaccine, Viral Vaccine
What are the major end-use applications of Plant-based Vaccines Market?
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
